Meta-Analysis The Journal of infection. 2022 Jun;84(6):834-872. doi: 10.1016/j.jinf.2022.03.011 Q114.32024
The effect of canakinumab on clinical outcomes in patients with COVID-19: A meta-analysis
卡那奴单抗对COVID-19患者临床结局影响的meta分析研究 翻译改进
作者单位 +展开
作者单位
DOI: 10.1016/j.jinf.2022.03.011 PMID: 35301014
摘要 中英对照阅读
Keywords：canakinumab; clinical outcomes; covid-19; meta-analysis
相关内容
-
Case Report: Canakinumab for the Treatment of a Patient With COVID-19 Acute Respiratory Distress Syndrome
案例报告：卡那奴单抗用于治疗COVID-19急性呼吸窘迫综合征患者
Frontiers in immunology. 2020 Aug 25:11:1942.
-
Canakinumab in a subgroup of patients with COVID-19
卡那奴单抗在COVID-19患者亚组中的应用
The Lancet. Rheumatology. 2020 Aug;2(8):e457-ee458.
-
A Meta-Analysis To Ascertain the Effectiveness of COVID-19 Vaccines on Clinical Outcomes in Patients With COVID-19 Infection in North America
一项元分析：评估COVID-19疫苗对北美地区新冠患者的临床结局的有效性
Cureus. 2023 Jun 27;15(6):e41053.
-
Does tocilizumab have an effect on the clinical outcomes in COVID-19 patients? A meta-analysis of randomized control trials
托珠单抗对新冠肺炎患者临床疗效的影响：随机对照试验的 Meta 分析研究
Journal of pharmaceutical policy and practice. 2023 Nov 20;16(1):151.
-
The effect of bebtelovimab on clinical outcomes in patients with COVID-19: A meta-analysis
贝特洛维玛对新冠患者的临床结局的影响：一项荟萃分析研究
The Journal of infection. 2023 Jul;87(1):68-71.
-
Paracetamol Use and COVID-19 Clinical Outcomes: A Meta-Analysis
对乙酰氨基酚的使用与新冠临床转归：一项 meta 分析
Healthcare (Basel, Switzerland). 2024 Nov 19;12(22):2309.
-
Markers of liver injury and clinical outcomes in COVID-19 patients: A systematic review and meta-analysis
新型冠状病毒肺炎患者肝损伤标志物与临床转归的系统评价和 meta 分析
The Journal of infection. 2021 Jan;82(1):159-198.
-
Use of canakinumab and remdesivir in moderate-severe COVID-19 patients: A retrospective analysis
卡那奴单抗和瑞德西韦在中重度COVID-19患者中的应用：回顾性分析
International journal of immunopathology and pharmacology. 2023 Jan-Dec:37:3946320231189993.
